Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban in the treatment of livedoid vasculopathy
DRKS00004652Phase 2Completed
- Sponsor
- Universitätsklinikum Münster
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rivaroxaban in livedoid vasculopathy (LV), sponsored by Universitätsklinikum Münster. Started Feb 2013; status: completed.
02
Drugs
rivaroxaban
03
Conditions
livedoid vasculopathy (LV)
Beyond the preview
Go deeper on DRKS00004652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00004652.